
Loading, please wait...

Loading, please wait...

The rapid evolution of digital platforms has fundamentally altered how infant nutrition products reach consumers globally. A comprehensive systematic scoping review reveals the pervasive nature of BMS marketing on social media, highlighting how commercial interests often overshadow evidence-based feeding practices. While traditional media marketing is heavily regulated in many regions, the digital landscape remains a complex frontier for public health. Consequently, healthcare providers must remain vigilant about the subtle yet persuasive tactics used to influence parental decisions regarding infant formula.
Marketing strategies in the digital age have moved beyond simple banner ads to more sophisticated, engagement-driven models. The scoping review identified that Facebook and Instagram are the primary platforms where companies like Nestle, Danone, and Mead Johnson actively promote their brands. These companies leverage user engagement features such as likes, shares, and comments to create a sense of community around their products. Furthermore, the use of digital tracking and algorithms allows these brands to target pregnant women and new parents with precision, often appearing in their feeds during vulnerable moments of early parenthood.
One of the most effective tools identified in the study is the use of social media influencers and parent bloggers. These individuals often blend commercial promotions with personal anecdotes, making the marketing feel authentic and peer-led rather than corporate. Moreover, live-streaming events and interactive sessions allow companies to bypass traditional advertising filters, providing direct-to-consumer access that traditional laws may not fully cover. This peer influence is particularly powerful, as it normalizes formula use and can inadvertently discourage exclusive breastfeeding.
In the Indian context, the Infant Milk Substitutes, Feeding Bottles, and Infant Foods Act (IMS Act) provides a robust legal framework intended to prohibit the promotion of breast milk substitutes. However, the rise of digital marketing presents significant enforcement challenges. Reports from organizations like the Breastfeeding Promotion Network of India (BPNI) indicate that companies frequently use social media to circumvent these regulations. Therefore, it is critical for clinicians to educate parents on how to distinguish between evidence-based nutritional advice and sponsored digital content. Monitoring these digital violations is now an urgent priority to ensure the integrity of the IMS Act and protect infant health.
Doctors and health workers play a pivotal role as the first line of defense against predatory marketing. Since digital content is often tailored to appear as helpful advice, clinicians should proactively discuss media literacy with families. By leveraging social media ourselves to share evidence-based breastfeeding support, we can counter the commercial narrative. Encouraging parents to rely on verified medical sources rather than influencer recommendations is essential for maintaining high breastfeeding rates across the country.
Unlike traditional media, social media marketing uses targeted algorithms and influencers to blend advertisements with personal content. This makes the promotion feel more like a peer recommendation than a commercial, often bypassing the regulatory oversight applied to TV or print ads.
Under the IMS Act, any form of promotion, including digital advertising and the use of influencers to market infant milk substitutes for children up to two years of age, is prohibited. Enforcement in the digital space, however, remains a significant challenge for regulatory bodies.
Providers should document the violation and report it to authorized monitoring bodies like the Breastfeeding Promotion Network of India (BPNI) or the Ministry of Women and Child Development to help strengthen digital enforcement.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. The information is based on a scoping review of global trends and should be interpreted within the specific legal framework of your jurisdiction. Refer to the latest local and national guidelines for clinical practice.
References
Cheng H et al. Breast Milk Substitutes Marketing on Social Media: A Systematic Scoping Review. Nutr Rev. 2026 May 21. doi: undefined. PMID: 42166183.
World Health Organization. Guidance on regulatory measures aimed at restricting digital marketing of breast-milk substitutes. Geneva: WHO; 2023.
Breastfeeding Promotion Network of India (BPNI). Indian Law Baby Food Offenders: A Report on IMS Act Violations. 2023-2025.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A scoping review reveals how BMS companies use social media influencers and targeted ads to influence infant feeding, posing challenges for the IMS Act in I...
5 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today